670 related articles for article (PubMed ID: 11818466)
21. [The psychopharmacology of the comorbid disorders associated with attention deficit hyperactivity disorder].
de la Osa-Langreo A; Mulas F; Téllez de Meneses M; Gandía R; Mattos L
Rev Neurol; 2007 Mar; 44 Suppl 2():S31-5. PubMed ID: 17347942
[TBL] [Abstract][Full Text] [Related]
22. Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman J
J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
[TBL] [Abstract][Full Text] [Related]
23. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
[TBL] [Abstract][Full Text] [Related]
24. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
Vaughan BS; Wetzel MW; Kratochvil CJ
Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204
[TBL] [Abstract][Full Text] [Related]
25. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
Steinhausen HC; Bisgaard C
Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
27. Attention-deficit/hyperactivity disorder.
Shaywitz BA; Fletcher JM; Shaywitz SE
Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
[TBL] [Abstract][Full Text] [Related]
28. BPD and ADHD.
Lombardo GT
J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):719-20. PubMed ID: 9183120
[No Abstract] [Full Text] [Related]
29. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
Spencer TJ; Biederman J; Mick E
J Pediatr Psychol; 2007 Jul; 32(6):631-42. PubMed ID: 17556405
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of adult attention-deficit/hyperactivity disorder.
Post RE; Kurlansik SL
Am Fam Physician; 2012 May; 85(9):890-6. PubMed ID: 22612184
[TBL] [Abstract][Full Text] [Related]
31. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
[TBL] [Abstract][Full Text] [Related]
32. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study.
Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV
J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365
[TBL] [Abstract][Full Text] [Related]
33. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
Hazell P
Australas Psychiatry; 2010 Dec; 18(6):556-9. PubMed ID: 21117844
[TBL] [Abstract][Full Text] [Related]
34. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Rowles BM; Findling RL
Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
[TBL] [Abstract][Full Text] [Related]
36. [Adult ADHD: clinical aspects and therapeutic implications].
Ceraudo G; Vannucchi G; Perugi G; Dell'osso L
Riv Psichiatr; 2012; 47(6):451-64. PubMed ID: 23160106
[TBL] [Abstract][Full Text] [Related]
37. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
[TBL] [Abstract][Full Text] [Related]
38. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
Greydanus DE; Pratt HD; Patel DR
Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
[TBL] [Abstract][Full Text] [Related]
39. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
40. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
